wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37604501-C2E4CF26-4EFC-429A-8ACD-9DF8EEDCE708
Q37604501-C2E4CF26-4EFC-429A-8ACD-9DF8EEDCE708
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-C2E4CF26-4EFC-429A-8ACD-9DF8EEDCE708
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
P50
Q37604501-C2E4CF26-4EFC-429A-8ACD-9DF8EEDCE708
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-C2E4CF26-4EFC-429A-8ACD-9DF8EEDCE708
rank
NormalRank
type
BestRank
Statement
P50
Paul Emery